Oldenlandia (Oldenlandia diffusa)

Oldenlandia diffusa, also called Bai Hua She She Cao in Traditional Chinese Medicine, contains bioactive compounds including ursolic acid, oleanolic acid, and flavonoids that drive its anticancer properties. These compounds inhibit tumor cell proliferation primarily by inducing apoptosis and modulating estrogen receptor alpha (ERα) signaling pathways.

Origin & History

Oldenlandia diffusa is an annual herbaceous plant from the Rubiaceae family, found in tropical and subtropical regions of Asia, Africa, and Australia. It is harvested, dried, and prepared as a decoction or extract for use in traditional Chinese medicine.

Historical & Cultural Context

Oldenlandia diffusa has been used for centuries in Traditional Chinese Medicine to treat cancer, arthritis, and inflammatory conditions. It is traditionally prepared as a decoction for detoxification and tumor treatment.

Health Benefits

• May reduce tumor size and number in hepatocellular carcinoma based on animal studies.[1][2]
• Exhibits antiproliferative and apoptotic effects on cancer cells in vitro.[1][6]
• Demonstrates selective inhibition of ERα-positive breast cancer cell growth without affecting normal cells in vitro.[6]
• Reduces inflammation by inhibiting the MAPK pathway in preclinical models.[4]
• Contains anti-inflammatory compounds, potentially beneficial for osteoarthritis.[4]

How It Works

Ursolic acid and oleanolic acid in Oldenlandia diffusa activate intrinsic apoptotic pathways by upregulating pro-apoptotic proteins such as Bax and downregulating anti-apoptotic Bcl-2, leading to caspase-3 activation in cancer cells. The herb selectively inhibits estrogen receptor alpha (ERα) signaling, suppressing proliferation in ERα-positive breast cancer cells while sparing normal breast epithelial cells. Polysaccharide fractions have also been shown to modulate immune function by enhancing macrophage activity and natural killer cell cytotoxicity, potentially contributing to antitumor effects in vivo.

Scientific Research

There are no human clinical trials or meta-analyses; all evidence is from preclinical in vitro and in vivo studies. Key studies include a rat model of hepatocellular carcinoma showing tumor reduction and improved survival with Oldenlandia diffusa treatment.[1][2]

Clinical Summary

Preclinical animal studies demonstrate that Oldenlandia diffusa extracts significantly reduce hepatocellular carcinoma tumor size and number in rodent models, though exact quantified reductions vary by extract preparation and dosage. In vitro studies consistently show antiproliferative and apoptotic effects across multiple cancer cell lines including liver, breast, and colorectal cancer cells. Human clinical trial data is largely absent or limited to small, poorly controlled studies, meaning the current evidence base is primarily preclinical. The overall evidence is promising but insufficient to support clinical recommendations without rigorous randomized controlled trials.

Nutritional Profile

Oldenlandia diffusa (Baihuasheshecao) is a medicinal herb with limited conventional nutritional profiling, but its bioactive constituents are well-documented. Key bioactive compounds include: iridoid glycosides (asperuloside, deacetylasperuloside, scandoside) at approximately 0.5–2% dry weight, which are primary active constituents; anthraquinones (2-hydroxy-3-methylanthraquinone, 2-methyl-3-hydroxyanthraquinone) at trace to low concentrations (~0.1–0.5% dry weight); flavonoids including quercetin, kaempferol, and luteolin glycosides collectively estimated at 0.3–1.5% dry weight; polysaccharides (β-glucans and heteropolysaccharides) comprising approximately 5–15% dry weight, contributing to immunomodulatory effects; phenolic acids including p-coumaric acid, caffeic acid, and chlorogenic acid at low concentrations (~0.1–0.8% dry weight); sterols including β-sitosterol and stigmasterol at trace levels; and ursolic acid and oleanolic acid (triterpenoids) at approximately 0.1–0.5% dry weight. Macronutrient content is not clinically characterized as a food source; it is consumed as a decoction or extract, not as a dietary staple. Mineral content includes trace potassium, calcium, and magnesium typical of leafy herbs. Bioavailability notes: iridoid glycosides are hydrolyzed in the gut to active aglycones; polysaccharide absorption is limited but exerts local gut immunomodulatory effects; flavonoids undergo hepatic first-pass metabolism with moderate bioavailability (10–30% estimated). Water-based decoctions (traditional preparation) primarily extract polysaccharides, iridoids, and polar flavonoids, while ethanolic extracts yield higher anthraquinone and terpenoid content.

Preparation & Dosage

Preclinical data suggest oral doses of 100-200 mg/kg twice daily in rats. No standardized human dosages are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Boswellia, Green Tea Extract, Resveratrol, Quercetin

Safety & Interactions

Oldenlandia diffusa is generally considered safe at traditional culinary and herbal doses, but systematic human safety data is lacking. Because of its potential estrogenic-modulating activity via ERα inhibition, individuals with hormone-sensitive conditions or those taking selective estrogen receptor modulators (SERMs) such as tamoxifen should exercise caution and consult a healthcare provider. Concurrent use with anticoagulant or immunosuppressant medications may carry theoretical interaction risks given its immune-modulating properties, though direct interaction studies in humans are not available. Pregnant and breastfeeding women should avoid use due to insufficient safety data.